Anti-inflammatory effects of tacrolimus in a rat model of acute pancreatitis

Medicinal Chemistry

Volumn 6, Issue 1, 2010, Pages 37-43

  Liu, Chaoxu ^a   Dou, Kefeng ^a   Dou, Chunqing ^a   Liu, Jianhua ^a   Zhao, Qingchuan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acute pancreatitis; Rat; Tacrolimus

Indexed keywords

AMYLASE; GLUCOCORTICOID; INTERLEUKIN 1BETA; SOMATOSTATIN; TACROLIMUS; TAUROCHOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEMORRHAGIC PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFECT; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LUNG EDEMA; LUNG INJURY; LUNG PARENCHYMA; MORPHOLOGY; MORTALITY; NONHUMAN; PANCREAS; PANCREAS INJURY; PRIORITY JOURNAL; RAT;

AMYLASES; ANIMALS; ANTI-INFLAMMATORY AGENTS; ASCITES; DISEASE MODELS, ANIMAL; INTERLEUKIN-1BETA; LUNG; ORGAN SIZE; PANCREAS; PANCREATITIS; RATS; RATS, SPRAGUE-DAWLEY; TACROLIMUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950909403     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340610791208745     Document Type: Article

References (41)

1. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13,1992. Arch Surg 1993, 128: 586-590
2. Cavallini G, Frulloni L. Somatostatin and octreotide in acute pancreatitis: the never-ending story. Dig Liver Dis 2001, 33: 192-201. (Pubitemid 32294184)
3. Wisner JR Jr, Renner IG, Grendell JH, Niederau C, Ferrell LD. Gabexate mesilate (FOY) protects against ceruletide-induced acute pancreatitis in the rat. Pancreas 1987; 2: 181-186.
4. Boruchowicz A, Gallon P, Foissey D, et al. [Acute pancreatitis associated with corticosteroid treatment in Crohn's disease] Gastroenterol Clin Biol 2003, 27: 560-561.
5. Khanna S, Kumar A. Acute pancreatitis due to hydrocortisone in a patient with ulcerative colitis. J Gastroenterol Hepatol 2003, 18: 1110-1111. (Pubitemid 37175958)
6. Malleo G, Mazzon E, Genovese T, et al. Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-alpha genetic deletion. Shock 2007; 27: 542-551. (Pubitemid 46626082)
7. Ulrich Christian Bang, Synne Semb, Camilla Nøjgaard, Flemming Bendtsen Pharmacological approach to acute pancreatitis. World J Gastroenterol 2008 May 21; 14: 2968-2976.
8. Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg 2002, 9: 401-410.
9. Pooran N, Indaram A, Singh P, Bank S. Cytokines (IL-6, IL-8, TNF): early and reliable predictors of severe acute pancreatitis. J Clin Gastroenterol 2003; 37: 263-266. (Pubitemid 37010923)
10. Kusske AM, Rongione AJ, Reber HA. Cytokines and acute pancreatitis. Gastroenterology 1996, 110: 639-642.
11. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20: 864-874.
12. Kino T, Hatanaka H, Miyata S, et al. FK506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibio. 1987, 40: 1256-1265. (Pubitemid 17138110)
13. De Bonis M, Reynolds L, Barros J, Madden BP. Tacrolimus as a rescue immunosuppressant after heart transplantation. Eur J Cardio-thorac Surg. 2001, 19: 690-695. (Pubitemid 32416622)
14. Gruessner RW, Bartlett ST, Burke GW, Stock PG. Suggested guidelines for the use of tacrolimus in pancreas/kidney transplantation. Clin Transplant. 1998, 12: 260-262. (Pubitemid 28269251)
15. Yanik G, Levine JE, Ratanatharathorn V, Dunn R, Ferrara J, Hutchinson RJ. Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation. Bone Marrow Transplant. 2000, 26: 161-167. (Pubitemid 30496962)
16. Reyes J, Jain A, Mazariegos G, Kashyap R, Green M, Iurlano K, Fung J. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. Transplantation 2000, 69: 2573-2580. (Pubitemid 30482024)
17. Shapiro R. Tacrolimus in pediatric renal transplantation: a review. Pediatr Transplant. 1998, 2: 270-276. (Pubitemid 128539690)
18. Dumont FJ. FK506, an immunosuppressant targeting calcineurin function. Curr Med Chem. 2000, 7: 731-748.
19. Echigo Y, Inoue K, Kogire M, et al. Effects of cyclosporine and tacrolimus (FK 506) on acute pancreatitis in mice. Arch Surg. 1995, 130: 64-68.
20. S. Ho, N. Clipstone, L. Timmermann, J. Northrop, I. Graef and D. Fiorentino et al., The mechanism of action of cyclosporine A and FK506. Clin Immunol Immunopathol. 1996; 80: S40-S45.
21. Hutchinson IV, Bagnall W, Bryce P, Pufong B, Geraghty P, Brogan I. Differences in the mode of action of cyclosporine and FK 506. Transplant Proc. 1998, 30: 959-960. (Pubitemid 28309440)
22. Fung J.J., Tacrolimus and transplantation: a decade in review. Transplantation. 2004, 77: S41-S43.
23. Aho HJ, Nevalainen TJ. Experimental pancreatitis in the rat. Uitrastructure of sodiumtauro cholate induced pancreatic lesions. Scand J Gastroenterol. 1980, 15: 417-424
24. Barnes P.J. and Karin M., Nuclear factor-Kappa B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997, 336: 1066-1071. (Pubitemid 27163860)
25. Barnes P.J. and. Adcock I.M, Transcription factors and asthma. Eur J Respir. 1998, 12: 221-234.
26. Cavallini G, Frulloni L. Somatostatin and octreotide in acute pancreatitis: the never-ending story. Dig Liver Dis 2001, 33: 192-201 (Pubitemid 32294184)
27. Schoonjans F, Zalata A, Depuydt CE, et al. MedCalc: a new computer program for medical statistics. Comput Methods Programs Biomed. 1995, 48:257-262. (Pubitemid 26020881)
28. Rau BM, Krüger CM, Hasel C, Oliveira V, Rubie C, Beger HG, Schilling MK. Effects of Immunosuppressive and Immunostimulative Treatment on Pancreatic Injury and Mortality in Severe Acute Experimental Pancreatitis. Pancreas 2006, 33:174-183. (Pubitemid 44174566)
29. Krause I, Valesini G, Scrivo R, et al. Autoimmune aspects of cytokine nd anticytokine therapies. Am J Med. 2003, 115:390-397. (Pubitemid 37311257)
30. Okamoto T, Yamada T, Kuno A, Ogawa K, Tang M. FTY720, an immunosuppressant, attenuates chronic pancreatitis in rats by suppressing T-cell infiltration Pancreas. 2005, 30:e64-70.
31. Uhl W, Buchler MW, Malfertheiner P, Beger HG, Adler G, Gaus W. A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut 1999, 45: 97-104. (Pubitemid 29301852)
32. Mumcu S, Alhan E, Turkyilmaz S, Kural BV, Ercin C, Kalyoncu NI. Effects of N-acetylcysteine on acute necrotizing pancreatitis in rats. Eur Surg Res 2005, 37: 173-178 (Pubitemid 41160150)
33. Ramudo L, Manso MA, Vicente S, De Dios I. Pro- and anti-inflammatory response of acinar cells during acute pancreatitis. Effect of N-acetyl cysteine. Cytokine 2005, 32: 125-131.
34. Esrefoglu M, Gul M, Ates B, Yilmaz I. Ultrastructural clues for the protective effect of ascorbic acid and N-acetylcysteine against oxidative damage on caerulein-induced pancreatitis. Pancreatology 2006, 6: 477-485. (Pubitemid 44624282)
35. Manso MA, Ramudo L, De Dios I. Extrapancreatic organ impairment during acute pancreatitis induced by bilepancreatic duct obstruction. Effect of N-acetylcysteine. Int J Exp Pathol 2007, 88: 343-349. (Pubitemid 47416544)
36. Siriwardena AK, Mason JM, Balachandra S, et al. Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis. Gut 2007, 56: 1439-1444. (Pubitemid 47517841)
37. Andriulli A, Leandro G, Federici T, Ippolito A, Forlano R, Iacobellis A, Annese V. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc 2007, 65: 624-632. (Pubitemid 46442832)
38. De Palma GD, Catanzano C. Use of corticosteriods in the prevention of post-ERCP pancreatitis: results of a controlled prospective study. Am J Gastroenterol 1999, 94: 982-985. (Pubitemid 29173614)
39. Budzynska A, Marek T, Nowak A, Kaczor R, Nowakowska-Dulawa E. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP induced pancreatitis. Endoscopy 2001, 33: 766-772. (Pubitemid 32834127)
40. Sherman S, Blaut U, Watkins JL, et al. Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study. Gastrointest Endosc 2003, 58: 23-29. (Pubitemid 38208742)
41. Schmidt J, Lewandrowski K, Fernandez-del Castillo C, et al. Histopathologic correlates of serum amylase activity in acute experimental pancreatitis. Dig Dis Sci. 1992, 37:1426-1433